Sciampa 25mg Tablet
Sciampa 25mg Tablet contains empagliflozin, an SGLT2 inhibitor for type 2 diabetes management and cardiovascular risk reduction. It promotes urinary glucose excretion to lower blood sugar independently of insulin, with added renal and cardiac protective effects. Prescription-only; once-daily dosing with or without food.
Pay in 3 Installments of
Rs.
214
Sciampa 25mg Tablet
Description
Sciampa 25mg Tablet — Empagliflozin SGLT2 Inhibitor
Sciampa 25mg Tablet contains empagliflozin 25mg, a sodium-glucose cotransporter-2 (SGLT2) inhibitor prescribed for the management of type 2 diabetes mellitus in adults. It is also indicated to reduce the risk of cardiovascular death and hospitalisation for heart failure in patients with type 2 diabetes and established cardiovascular disease or high cardiovascular risk, and to slow the progression of chronic kidney disease. This medicine requires a valid prescription from a licensed physician.
Empagliflozin works by blocking SGLT2 receptors in the renal proximal tubule, preventing glucose reabsorption and promoting glucosuria (excretion of glucose in urine). This mechanism lowers blood glucose levels independently of insulin, and also provides beneficial effects on blood pressure, body weight, and renal function.
Clinical Indications
- Type 2 diabetes mellitus — blood glucose control
- Reduction of cardiovascular death risk in high-risk patients
- Hospitalisation reduction for heart failure
- Slowing progression of chronic kidney disease
Browse our range of prescription diabetes tablets at Derma.pk or explore more general medicines available online in Pakistan.
Take once daily with or without food as prescribed. Do not discontinue without medical advice. Monitor for urinary tract infections and signs of dehydration. Prescription required.
Usage & Benefits
- Lowers blood glucose in type 2 diabetes via SGLT2-mediated glucosuria
- Reduces risk of cardiovascular death and hospitalisation in heart failure
- Slows progression of diabetic chronic kidney disease
- Insulin-independent mechanism provides complementary glycaemic control
- Modest reductions in blood pressure and body weight as secondary benefits
How To Use
Take one Sciampa 25mg tablet once daily as prescribed by your physician, with or without food. Swallow whole with a glass of water. Do not crush or chew. Stay well hydrated during treatment. Monitor for symptoms of urinary tract infections or genital mycotic infections and report to your doctor. Do not stop taking this medicine without consulting your physician, even if blood sugar appears controlled.
FAQs
What is Sciampa 25mg used for?
Sciampa 25mg controls blood glucose in adults with type 2 diabetes. It also reduces the risk of cardiovascular death and hospitalisation in patients with heart failure or chronic kidney disease.
How does empagliflozin lower blood sugar?
Empagliflozin blocks SGLT2 receptors in the kidneys, preventing glucose reabsorption and promoting its excretion in urine — lowering blood glucose without requiring insulin.
Is a prescription required for Sciampa 25mg?
Yes. Sciampa 25mg is a prescription-only SGLT2 inhibitor. It must be initiated and monitored by a licensed physician.



